Meeting
2021 ASCO Annual Meeting
A pilot study of the feasibility and utility of a fitness tracker to correlate activity level with patient reported outcomes (PROs) in sarcoma patients undergoing systemic therapy.
Authors
Elizabeth J. Davis
Vanderbilt University, Nashville, TN
Elizabeth J. Davis , G. Dan Ayers , Deborah Wallace , Elizabeth Kaiser , Vicki Leigh Keedy , Rajiv Agarwal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 11559)
DOI
10.1200/JCO.2021.39.15_suppl.11559
Abstract #
11559
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A prospective study evaluating the association of patient-reported outcomes with activity level and sleep patterns in sarcoma survivors.
First Author: Elizabeth J. Davis
Poster
2024 ASCO Annual Meeting
Patient-reported outcomes (PROs) from the DREAMM-7 randomized phase 3 study comparing belantamab mafodotin, bortezomib, and dexamethasone (BVd) vs daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed/refractory multiple myeloma (RRMM).
First Author: Vania Hungria
Poster
2024 ASCO Annual Meeting
Prospective evaluation of the effect of 3 days of post-chemotherapy dexamethasone on patient reported symptoms in gynecologic oncology patients treated with carboplatin and paclitaxel.
First Author: Hayley Hart
Poster
2024 ASCO Genitourinary Cancers Symposium
Patient reported outcomes (PROs) among patients with metastatic castration-resistant prostate cancer (mCRPC) by homologous recombination repair mutations (HRRm) gene clusters: Findings from the phase 3 TALAPRO-2 study cohort 2.
First Author: Karim Fizazi